EDX Medical Group (EDX.AQ) Stock Price

EDX Medical Group Plc generates revenue through the sale of digitally enabled diagnostic products and services to individuals and organizations. The company offers point-of-care, home, and workplace testing tools that allow personalized diagnosis according to international standards. Its disease surveillance solutions are sold to cross-border agencies and governments for identifying new disease variants with high transmission risks. The firm also partners with researchers and clinicians to commercialize their discoveries into marketable products. The primary buyers of EDX Medical Group's diagnostic tools include healthcare professionals, individuals seeking personal health monitoring, and government agencies responsible for public health surveillance. Cross-border agencies utilize the disease surveillance solutions to track rapidly spreading variants. Researchers and clinicians form strategic partnerships to develop and launch new diagnostic products through the company's platform. EDX Medical Group's product portfolio consists of diagnostic tests for point-of-care, home, and workplace use, alongside disease surveillance systems. The company's services focus on enabling personalized medical diagnosis and early detection of disease variants. Revenue streams are derived from direct sales of diagnostic tools, government contracts for surveillance systems, and partnership agreements with research institutions.